Medicamen Biotech informs about press release

31 May 2024 Evaluate
Pursuant to regulation 30 & 47 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015 (the Regulations), Medicamen Biotech has informed that it enclosed newspaper cutting with regard to the publication of extract of Audited Financial Results of the Company for the quarter and year ended on March 31, 2024 approved by the Board of Directors at their Meeting held on 29.05.2024. The copy of the results published in the Financial Express and Jansatta dated May 30, 2024 is enclosed.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

352.70 -13.40 (-3.66%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×